Hassan to testify in Celebrex suit

Schering-Plough CEO Fred Hassan has been ordered to testify via videotape in a trial over the painkiller Celebrex, which Pfizer acquired in its merger with Pharmacia--the company that was headed up by Hassan when Celebrex was launched. Though Pfizer has settled some Celebrex lawsuits, brought by plaintiffs who said the painkiller caused their heart attacks or strokes, this is the first such suit to reach trial. Report

Suggested Articles

Pfizer has scored FDA approval for its Humira biosimilar, but it can't launch the product for several years under a patent settlement.

The 3-2 vote on the deal was split along the party lines, spelling trouble for future biopharma M&A deals should Democrats move into the White House.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.